Despite widespread financial uncertainty, U.S. Oral Surgery Management (USOSM) is heading into 2023 with increased capital. The Irving-based company has closed on a $125 million credit expansion. This year, USOSM has experienced incredible growth – adding $100 million in acquired revenue. This new round of financing will position USOSM for similar growth in 2023 and beyond.
“We’re expanding our credit facility with our existing lenders. This additional capital will fund our continued growth in 2023 and carry us well into 2024,” said USOSM President and CEO Richard Hall. “The credit markets are particularly difficult right now, given the state of the economy. Only companies with well-established track records and exceptional performance will have access to capital at reasonable terms. We’re proud that USOSM’s performance provided our lenders the confidence to expand their commitment. This additional dry powder and our track record of timely closings will give future partners confidence around certainty to close.”
USOSM Chief Financial Officer Henry Moomaw added, “USOSM and our equity backer, Oak Hill Capital (OHC), began earnestly planning and pursuing a credit expansion this summer, despite capital market challenges. This exemplifies the level of confidence our lenders have in USOSM.” OHC is a longstanding private equity firm focused on the North America middle-market.
Founded in November 2017, USOSM is a shared-services company that exclusively serves premier oral and maxillofacial surgeons. The first company of its kind, USOSM continues to lead the industry today with more than 160 oral and maxillofacial surgery practice locations across 24 states.
USOSM has a 100% partner practice retention rate and nearly 50% of the company is owned by the oral surgeons themselves. In addition, USOSM partner practices consistently achieve a Net Promoter Score (NPS) ™ of 80 or above, a feat that’s recognized as “world-class” by one of the ranking system’s founders: Bain & Company.
“We’re excited to continue to be recognized as a leader in this industry. Everything we do, we do with our surgeon partners and their patients in mind, and it shows. We continue to grow, despite increasing competition, the economic fallout from the COVID 19 pandemic, rising interest rates and widespread macroeconomic volatility,” noted Hall.
Hall added that another driving force behind USOSM’s phenomenal growth is the quality of its surgeon partners. “We’ve always been highly selective about with whom we partner. Our partners are industry leaders. They are all board certified, highly trained and highly skilled. They’re also true partners – they all have an equity stake in USOSM and complete clinical autonomy.”
